Clinical Trial Update: Study on the Safety of the Drug Runcaciguat and How Well it Works When Given at the Highest Dose as Tolerated by Individual Patient Whose Kidneys Are Not Working Properly and Suffering at the Same Time From High Blood Sugar and/or High Blood Pressure and a Disease of the Heart and the Blood Vessels. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of the highest tolerated dose of runcaciguat in adults with chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Runcaciguat (runcaciguat)

Snippet

Sponsor: Bayer | Conditions: Chronic Kidney Disease | Phase 2 | Status: COMPLETED